John T Schousboe1, Tien N Vo2, Lisa Langsetmo2, Selcuk Adabag2, Pawel Szulc3, Joshua R Lewis4, Allyson M Kats2, Brent C Taylor5, Kristine E Ensrud5. 1. Park Nicollet Clinic and HealthPartners Institute, Minneapolis, MN, USA; University of Minnesota, Minneapolis, MN, USA. Electronic address: scho0600@umn.edu. 2. University of Minnesota, Minneapolis, MN, USA. 3. INSERM, University of Lyon, Lyon, France. 4. Edith Cowan University, Perth, Australia; Medical School, University of Western Australia, Perth, Australia; Centre for Kidney Research, School of Public Health, The University of Sydney, Sydney, Australia. 5. University of Minnesota, Minneapolis, MN, USA; Center for Care Delivery & Outcomes Research, VA Health Care System, Minneapolis, MN, USA.
Abstract
BACKGROUND AND AIMS: Abdominal aortic calcification (AAC) and low ankle-brachial index (ABI) are markers of multisite atherosclerosis. We sought to estimate their associations in older men with health care costs and utilization adjusted for each other, and after accounting for CVD risk factors and prevalent CVD diagnoses. METHODS: This was an observational cohort study of 2393 community-dwelling men (mean age 73.6 years) enrolled in the Osteoporotic Fractures in Men (MrOS) study and U.S. Medicare Fee for Service (FFS). AAC was scored on baseline lateral lumbar spine X-rays using a 24-point scale. ABI was measured as the lowest ratio of arm to right or left ankle blood pressure. Health care costs, hospital stays, and SNF stays were identified from Medicare FFS claims over 36 months following the baseline visit. RESULTS: Men with AAC score ≥9 (n = 519 [21.7% of analytic cohort]) had higher annualized total health care costs of $1473 (95% C.I. 293, 2654, 2017 U S. dollars) compared to those with AAC score 0-1, after multivariable adjustment. Men with ABI <0.90 (n = 154 [6.4% of analytic cohort]) had higher annualized total health care costs of $2705 (95% CI 634, 4776) compared to men with normal ABI (≥0.9 and < 1.4), after multivariable adjustment. CONCLUSIONS: High levels of AAC and low ABI in older men are associated with higher subsequent health care costs, after accounting for clinical CVD risk factors, prevalent CVD diagnoses, and each other. Further investigations of whether preventing progression of peripheral vascular disease and calcification reduces subsequent health care costs are warranted.
BACKGROUND AND AIMS: Abdominal aortic calcification (AAC) and low ankle-brachial index (ABI) are markers of multisite atherosclerosis. We sought to estimate their associations in older men with health care costs and utilization adjusted for each other, and after accounting for CVD risk factors and prevalent CVD diagnoses. METHODS: This was an observational cohort study of 2393 community-dwelling men (mean age 73.6 years) enrolled in the Osteoporotic Fractures in Men (MrOS) study and U.S. Medicare Fee for Service (FFS). AAC was scored on baseline lateral lumbar spine X-rays using a 24-point scale. ABI was measured as the lowest ratio of arm to right or left ankle blood pressure. Health care costs, hospital stays, and SNF stays were identified from Medicare FFS claims over 36 months following the baseline visit. RESULTS:Men with AAC score ≥9 (n = 519 [21.7% of analytic cohort]) had higher annualized total health care costs of $1473 (95% C.I. 293, 2654, 2017 U S. dollars) compared to those with AAC score 0-1, after multivariable adjustment. Men with ABI <0.90 (n = 154 [6.4% of analytic cohort]) had higher annualized total health care costs of $2705 (95% CI 634, 4776) compared to men with normal ABI (≥0.9 and < 1.4), after multivariable adjustment. CONCLUSIONS: High levels of AAC and low ABI in older men are associated with higher subsequent health care costs, after accounting for clinical CVD risk factors, prevalent CVD diagnoses, and each other. Further investigations of whether preventing progression of peripheral vascular disease and calcification reduces subsequent health care costs are warranted.
Authors: Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone Journal: Contemp Clin Trials Date: 2005-10 Impact factor: 2.226
Authors: Rebecca E Scully; Dean J Arnaoutakis; Ann DeBord Smith; Marcus Semel; Louis L Nguyen Journal: J Vasc Surg Date: 2017-08-25 Impact factor: 4.268
Authors: Thom W Rooke; Alan T Hirsch; Sanjay Misra; Anton N Sidawy; Joshua A Beckman; Laura K Findeiss; Jafar Golzarian; Heather L Gornik; Jonathan L Halperin; Michael R Jaff; Gregory L Moneta; Jeffrey W Olin; James C Stanley; Christopher J White; John V White; R Eugene Zierler Journal: J Am Coll Cardiol Date: 2011-10-06 Impact factor: 24.094
Authors: Pawel Szulc; Terri Blackwell; Douglas P Kiel; John T Schousboe; Jane Cauley; Teresa Hillier; Marc Hochberg; Nicolas Rodondi; Brent C Taylor; Dennis Black; Steven Cummings; Kristine E Ensrud Journal: Bone Date: 2015-06-24 Impact factor: 4.398
Authors: Tracie C Collins; Susan K Ewing; Susan J Diem; Brent C Taylor; Eric S Orwoll; Steven R Cummings; Elsa S Strotmeyer; Kristine E Ensrud Journal: Circulation Date: 2009-04-20 Impact factor: 29.690
Authors: M Hollander; A E Hak; P J Koudstaal; M L Bots; D E Grobbee; A Hofman; J C M Witteman; M M B Breteler Journal: Stroke Date: 2003-09-04 Impact factor: 7.914
Authors: Birgitta Sigvant; Katarina Wiberg-Hedman; David Bergqvist; Olov Rolandsson; Bob Andersson; Elisabeth Persson; Eric Wahlberg Journal: J Vasc Surg Date: 2007-06 Impact factor: 4.268
Authors: Amanda J Cox; Fang-Chi Hsu; Subhashish Agarwal; Barry I Freedman; David M Herrington; J Jeffrey Carr; Donald W Bowden Journal: Cardiovasc Diabetol Date: 2014-12-12 Impact factor: 9.951
Authors: John T Schousboe; Lisa Langsetmo; Pawel Szulc; Joshua R Lewis; Brent C Taylor; Allyson M Kats; Tien N Vo; Kristine E Ensrud Journal: J Bone Miner Res Date: 2021-03-17 Impact factor: 6.741